PSI specializes in pivotal phase 2 and phase 3 clinical trials in oncology, hematology, gastroenterology, autoimmune, infectious diseases, neurology, and other indications. We provide expertise in complex trials at the forefront of precision medicine, including platform and umbrella designs, trials in targeted immunotherapy, radiopharmaceuticals, and cell and gene therapies.
And it’s not just sites. Our sponsors enjoy working with PSI so much that we have a 95% repeat and referral business rate.
If you’re ready for a CRO that puts your study first, complete the form to schedule a meeting.
"*" indicates required fields
PSI specializes in pivotal phase 2 and phase 3 clinical trials in oncology, hematology, gastroenterology, autoimmune, infectious diseases, neurology, and other indications. We provide expertise in complex trials at the forefront of precision medicine, including platform and umbrella designs, trials in targeted immunotherapy, radiopharmaceuticals, and cell and gene therapies.
93% of our studies enrolled on time or ahead of schedule in 2024, thanks in part to our proprietary machine-learning-enabled feasibility tool, VISIONAL™. Along with our unique approach to site support, this results in faster study start-up and much more reliable patient enrollment. Sites around the world love working with us, which means your study stands out from the crowd.
And it’s not just sites. Our sponsors enjoy working with PSI so much that we have a 95% repeat and referral business rate.
If you’re ready for a CRO that puts your study first, complete the form to schedule a meeting.
"*" indicates required fields